Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine Plus Irinotecan in Metastatic Renal Cell Carcinoma
NCT00401128Phase 2Completed
- Sponsor
- Cleveland Clinic
- Start
- May 2004
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, irinotecan in renal cell carcinoma (RCC), sponsored by Cleveland Clinic. Started May 2004; status: completed.
02
Drugs
gemcitabineirinotecan
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00401128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401128.